Price targets show what analysts believes a stock will be worth at the end of a certain time period. About 838,829 shares traded. (NYSE:BAX) by 9.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. It has outperformed by 15.85% the S&P500.
Pura Vida Investments Llc decreased its stake in Baxter Intl Inc (BAX) by 30.56% based on its latest 2017Q2 regulatory filing with the SEC. The firm purchased 23,258 shares of the medical instruments supplier's stock, valued at approximately $1,459,000. At the close of regular trading, its last week's stock price volatility was 5.36% which for the month reaches 4.85%. About 245,264 shares traded. Synalloy Corporation (NASDAQ:SYNL) has risen 59.68% since November 30, 2016 and is uptrending. It has outperformed by 0.45% the S&P500. Of those analysts, 4 rate stock as a Strong Buy, 9 rate it as Hold, and just 1 analyst rates it as a Moderate Sell. Therefore 73% are positive.
Analysts await (:) to report earnings on February, 7. The firm has "Buy" rating by Stifel Nicolaus given on Friday, July 14. The company was maintained on Monday, September 11 by Jefferies. Goldman Sachs has "Neutral" rating and $24 target. Barclays Capital maintained KKR & Co. (NYSE:BAX) on Thursday, August 17 with "Hold" rating. (NYSE:BAX) on Tuesday, July 11 to "Outperform" rating. Keybank Natl Association Oh reported 84,760 shares. The company moved in the past week with shift of 1.45%. Its up 0.28, from 0.8 in 2017Q1. 74 funds opened positions while 313 raised stakes. Livingston Group Asset Management CO operating as Southport Capital Management now owns 18,079 shares of the medical instruments supplier's stock valued at $938,000 after buying an additional 54 shares during the period. Interocean Limited Liability Co reported 0.11% of its portfolio in KKR & Co. Perhaps, that suggests something about why 88.06% of the outstanding share supply is held by institutional investors. Ameriprise, Minnesota-based fund reported 95,107 shares. Ltd now owns 2,928 shares of the medical instruments supplier's stock valued at $177,000 after purchasing an additional 226 shares in the last quarter. During the same quarter in the prior year, the business posted $0.56 earnings per share. Evercore Wealth Ltd Liability Com holds 0.02% or 8,827 shares. (NYSE:BAX) for 5,040 shares. Nine Chapters Capital Management Llc owns 5,200 shares or 1.97% of their U.S. portfolio. Aviva Public Limited Co invested in 83,711 shares.
Euclidean Technologies Management Llc holds 2.04% of its portfolio in Insight Enterprises, Inc. for 52,974 shares.
Doctor Loses Her Medical License for Refusing to Use Computers
In October, Konopka surrendered her license to practice, but later asked for permission to continue seeing patients. Two file cabinets in a tiny waiting room inside a 160-year-old clapboard house hold most of her patient records.
Bluecrest Capital Management Ltd decreased Genesee & Wyo Inc (NYSE:GWR) stake by 113,292 shares to 58,153 valued at $3.98M in 2017Q2. Following the transaction, the senior vice president now owns 49,966 shares in the company, valued at $2,782,606.54. There has been an observed change of -94.86% in the ownership of the shares in the past six months. Cl V was reduced too. Its down 0.09, from 1.11 in 2017Q1. Of those transactions, there were 350,605 shares of BAX bought and 16.17 million shares sold.
ILLEGAL ACTIVITY NOTICE: "Nordea Investment Management AB Raises Stake in Baxter International Inc". Analysts are forecasting earnings of $0.59 on a per share basis this quarter. Schulhoff And Inc holds 0.17% in Baxter International Inc. Quantum Cap Management reported 26,687 shares. The Alberta - Canada-based Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Mngmt Corporation has invested 0.04% in Baxter International Inc. 130,540 were accumulated by Comerica Savings Bank. (NYSE:BAX). Mawer Inv Mgmt Limited has invested 0.36% in Baxter International Inc. Mercer Capital Advisers holds 200 shares or 0.01% of its portfolio. Ghp Investment Advsrs invested in 0.12% or 12,984 shares. Sumitomo Mitsui Asset Company Limited has 38,351 shares for 0.04% of their portfolio. Allen Ltd Liability reported 0.04% in Baxter International Inc. That compares with the recent volume average of 20.81 million. However, 0.56% over the last one month, 7.56% for the last quarter and year to date performance stands at 48.96%. The stock has a market capitalization of $35,986.14, a PE ratio of 27.29, a P/E/G ratio of 2.21 and a beta of 0.68. After $0.64 actual EPS reported by Baxter International Inc for the previous quarter, Wall Street now forecasts -7.81% negative EPS growth.
Shares of Baxter International Inc. The Firm operates through two divisions: Hospital Products and Renal. The Company's Hospital Products business makes sterile intravenous solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. Axa holds 315,939 shares or 0.09% of its portfolio. Therefore 50% are positive. The stock of Baxter International Inc. BMO Capital Markets reaffirmed a "buy" rating and issued a $70.00 target price on shares of Baxter International in a research report on Friday, October 13th. Numeric Invsts Lc stated it has 1.46% in Baxter International Inc (NYSE:BAX). The stock has "Overweight" rating by Cantor Fitzgerald on Friday, June 30. On Thursday, August 3 the stock rating was maintained by Barclays Capital with "Overweight". The company was upgraded on Tuesday, April 4 by Leerink Swann. The stock of Baxter International Inc (NYSE:BAX) has "Hold" rating given on Monday, July 10 by RBC Capital Markets. (NYSE BAX) opened at $64.74 on Tuesday. On Wednesday, October 28 the stock rating was maintained by Leerink Swann with "Market Perform". Finally, Bessemer Group Inc. lifted its holdings in shares of Baxter International by 42,907.2% in the second quarter.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.